Mammalian cells undergo irreversible proliferation arrest when exposed to stresses, a phenomenon termed cellular senescence. Various types of stress induce cellular senescence; nonetheless, senescent cells show similar phenotypes overall. Cells undergo cellular senescence…
Abstract
Mammalian cells undergo irreversible proliferation arrest when exposed to stresses, a phenomenon termed cellular senescence. Various types of stress induce cellular senescence; nonetheless, senescent cells show similar phenotypes overall. Cells undergo cellular senescence through similar mechanisms, regardless of the type of stress encountered. Here, we aimed to reveal the mechanisms underlying cellular senescence. We have previously shown that lamin B receptor (LBR), which is a protein that regulates heterochromatin organization, was downregulated in senescent cells, and downregulation of LBR induced cellular senescence. Additionally, we have shown that downregulation of protein synthesis effectively suppressed cellular senescence. Accordingly, chromatin organization and protein synthesis are implicated in the regulation of this process. We examined their roles and revealed that protein synthesis was upregulated during the induction of cellular senescence, and upregulated protein synthesis caused disturbed proteostasis that led to the decreased LBR protein levels. Furthermore, we showed that decreased LBR protein levels induced cellular senescence through altered chromatin organization and increased genome instability. Importantly, these findings revealed a link between protein synthesis and chromatin organization, and accounted for the phenotypes of senescent cells showing disturbed proteostasis, altered chromatin organization and increased genome instability. Our findings provide novel insights into the mechanisms of cellular senescence.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that disturbed proteostasis, triggered by upregulated protein synthesis, leads to decreased Lamin B receptor levels, which in turn alters chromatin organization and induces cellular senescence. This is relevant to longevity research because it identifies a specific mechanistic pathway linking protein homeostasis to the senescence phenotype, a key driver of aging, offering potential targets for interventions aimed at delaying or reversing cellular aging.
Regeneration restores tissues lost to injury, but its consequences may extend beyond local repair. Whether regeneration produces lasting systemic effects on developmental timing and lifespan remains poorly understood. Here we investigated the long-term consequences of repeated…
Abstract
Regeneration restores tissues lost to injury, but its consequences may extend beyond local repair. Whether regeneration produces lasting systemic effects on developmental timing and lifespan remains poorly understood. Here we investigated the long-term consequences of repeated regeneration in the marine annelid Platynereis dumerilii. To determine these consequences, we repeatedly amputated juveniles at monthly intervals, removing approximately half of the body after each regenerative cycle, and compared them with control unamputated siblings. Repeatedly regenerating worms lived approximately 1.5-fold longer than controls and showed delayed sexual maturation, including delayed gametogenic progression at the morphological and transcriptional levels. Somatic progression was also delayed, as indicated by slower accumulation of pigmentation associated with developmental progression, while regenerative competence was maintained across amputations. To investigate whether regeneration engages distant tissues, we compared head transcriptomes from amputated and unamputated worms. Posterior amputation altered head gene expression within 2 hours, including increased expression of genes associated with younger head profiles, such as igf-like and alpha-tubulin. Together, our results show that repeated regeneration not only restores lost tissues but prolongs the juvenile state, delays reproductive and somatic maturation, and extends lifespan, a phenomenon we term the Highlander effect. These findings suggest that regeneration may influence organismal life history beyond tissue replacement, with neurohormonal signaling as a potential mediator.
AI-generated longevity analysis. Check claims against the paper.
Summary
Repeated regeneration in Platynereis dumerilii prolongs the juvenile stage and extends lifespan by delaying sexual and somatic maturation. This is relevant because it identifies a specific physiological mechanism (the "Highlander effect") where tissue regeneration actively alters developmental timing and extends lifespan, providing a model to study the systemic signaling pathways that link regeneration to aging and life history.
The mutation accumulation theory attributes aging to the decline in selection strength with age. While classical models assume fixed ages of mutation expression, empirical evidence reveals significant interindividual variation in the timing of mutation expression. Here, we…
Abstract
The mutation accumulation theory attributes aging to the decline in selection strength with age. While classical models assume fixed ages of mutation expression, empirical evidence reveals significant interindividual variation in the timing of mutation expression. Here, we develop mathematical models incorporating this stochasticity. By tracking the fate of lethal mutations, we characterize the boundary of the "selection shadow" where genetic drift overcomes purging selection against such mutations-a fundamental evolutionary limit, termed the lifespan drift barrier, setting a theoretical benchmark for the pace of aging. Our results show that for both stochastic age- and state-dependent mutations, variation in the age of mutation expression generally pushes back this lifespan drift barrier. This outcome is a universal consequence of the inherent convexity of the selection gradient under extrinsic mortality: early expression in a subset of individuals intensifies purging selection, thereby raising the drift barrier. In addition, we demonstrate that while this variance shifts this evolutionary threshold (determining the pace of aging), it leaves the mortality trajectory at mutation-selection balance (the shape of aging) fundamentally unaltered. These findings thus help explain how the pace and shape of aging can become uncoupled.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that stochastic variation in the timing of mutation expression pushes back the evolutionary limit of lifespan (the drift barrier) without altering the shape of the mortality trajectory. This is relevant because it provides a theoretical framework explaining how the pace of aging can be extended beyond classical mutation accumulation predictions, offering insights into the fundamental evolutionary constraints on longevity.
Changes in the metabolic network that sustain NAD+ during aging remain poorly understood. Analysis of steady state levels is insufficient to reveal whether biosynthetic or consumption pathways are perturbed or preserved. Here, we address this gap in understanding by integrating…
Abstract
Changes in the metabolic network that sustain NAD+ during aging remain poorly understood. Analysis of steady state levels is insufficient to reveal whether biosynthetic or consumption pathways are perturbed or preserved. Here, we address this gap in understanding by integrating metabolomics, proteomics, gene-expression profiling, and stable-isotope tracing across the Caenorhabditis elegans adult lifespan. NAD abundance increases with age despite reductions in selected biosynthetic components. Tracing reveals reduced mid-adult incorporation of nicotinamide and nicotinic acid into NAD, alongside declining nicotinamide riboside abundance and loss of detectable nicotinic acid-derived labeling into this precursor. Early mitochondrial Complex I remodeling accompanies sustained changes in redox and energetic indices. Disruption of NAD-consuming or salvage enzymes reduces reproduction and lifespan, whereas precursor supplementation provides no longevity benefit under the conditions tested. Together, these findings reveal that NAD accumulation can coexist with extensive metabolic remodeling, establishing the importance of evaluating network dynamics beyond cofactor abundance.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that NAD+ accumulation in aging C. elegans coexists with extensive metabolic remodeling and that precursor supplementation does not extend lifespan under the tested conditions. This is relevant because it challenges the prevailing "NAD+ decline" hypothesis by showing that cofactor abundance is not the sole determinant of aging, thereby refining the mechanistic understanding of metabolic networks in longevity.
Telomere shortening is a hallmark of aging, yet telomere length (TL) varies considerably between individuals and is strongly influenced by inheritance. In mice, efficient mitochondrial function and low reactive oxygen species (ROS) production are essential for telomere…
Abstract
Telomere shortening is a hallmark of aging, yet telomere length (TL) varies considerably between individuals and is strongly influenced by inheritance. In mice, efficient mitochondrial function and low reactive oxygen species (ROS) production are essential for telomere elongation during early embryogenesis. As mitochondrial DNA (mtDNA) encodes several subunits of the electron transport chain, we investigated whether mtDNA variants influence TL using a transmitochondrial cybrid model. Platelet-derived mitochondria from human donors with varying TL were introduced into mtDNA-depleted cells. Donor blood TL inversely correlated with cybrid ROS levels, suggesting that specific mtDNA variants may support telomere maintenance by enhancing mitochondrial fitness. During cybrid formation, a transient oxidative stress phase precedes cellular adaptation. At this stage, mtDNA variants associated with reduced complex I (CI) activity triggered rapid telomere shortening, which was rescued by antioxidant and NAD
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that specific human mitochondrial DNA variants influence telomere length by modulating mitochondrial fitness and reactive oxygen species levels. This is relevant to longevity research because it identifies a potential mechanistic link between mitochondrial genetic variation and a core hallmark of aging (telomere shortening), offering insights into the genetic determinants of cellular aging rates.
Frailty summarizes aging-related decline independently of chronological age. Although the gut microbiome covaries with frailty in older populations, its causal contribution to frailty remains unclear. We profiled middle-aged (72-week-old) and young (10-week-old) male mice across…
Abstract
Frailty summarizes aging-related decline independently of chronological age. Although the gut microbiome covaries with frailty in older populations, its causal contribution to frailty remains unclear. We profiled middle-aged (72-week-old) and young (10-week-old) male mice across six data layers including physio-behavioral phenotypes, fecal metagenomic taxa and pathways, serum lipidome, and liver and hippocampal transcriptomes. Aged mice exhibited elevated frailty, reduced motor coordination, and microbiome alterations, with members of
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that depleting the gut microbiome in late-life attenuates aging-induced frailty in male mice. This is relevant because it investigates a causal mechanism linking the microbiome to the physiological decline of aging, rather than just treating a specific age-related disease symptom.
Autophagy is an essential catabolic pathway that safeguards cellular and tissue homeostasis, yet the systemic consequences of its impairment in mammals remain poorly defined because complete autophagy ablation is embryonic or perinatal lethal. Here, we generate ATG4A-only mice…
Abstract
Autophagy is an essential catabolic pathway that safeguards cellular and tissue homeostasis, yet the systemic consequences of its impairment in mammals remain poorly defined because complete autophagy ablation is embryonic or perinatal lethal. Here, we generate ATG4A-only mice, a model in which ATG4A is the sole remaining ATG4 protease due to combined ATG4B/C/D deletion. Through comprehensive biochemical and cellular analyses, we delineate the in vivo substrate specificity of ATG4A and demonstrate that it sustains only minimal ATG8 priming, uncovering a previously unrecognized functional asymmetry within the mammalian ATG4-ATG8 system. ATG4A-only mice exhibit a profound but incomplete whole-body autophagy deficiency that disrupts multiple organ systems and triggers a premature aging syndrome marked by increased DNA damage, systemic senescence, metabolic dysfunction, and dramatically shortened lifespan. Integrating these findings with comparisons to additional ATG4-deficient models, we show that organismal longevity scales with residual autophagic competence. Together, our work reveals how graded reductions in autophagy integrity influence tissue fitness and aging, establishing autophagic capacity as a key determinant of mammalian lifespan.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that organismal longevity in mammals scales directly with residual autophagic competence, establishing autophagy capacity as a fundamental determinant of lifespan. This is highly relevant because it provides a genetic model for a premature aging syndrome caused by systemic autophagy impairment, offering critical insights into the root cause of aging and validating autophagy as a key target for lifespan extension interventions.
Elevated circulating very-long-chain ceramides are associated with increased cardiovascular disease risk, yet the underlying mechanisms remain unclear. Here, we identify ceramide synthase 2 (CerS2)-derived Cer 24:0 as a critical mediator of endothelial senescence-a key driver of…
Abstract
Elevated circulating very-long-chain ceramides are associated with increased cardiovascular disease risk, yet the underlying mechanisms remain unclear. Here, we identify ceramide synthase 2 (CerS2)-derived Cer 24:0 as a critical mediator of endothelial senescence-a key driver of cardiovascular disease progression. CerS2 was upregulated in senescent HUVECs and in aortas from aged mice, coinciding with marked Cer 24:0 elevation. Isotopic labeling confirmed that excess Cer 24:0 accumulates in mitochondria, triggering structural damage and mtDNA release into the cytosol, thereby activating the cGAS-STING pathway, driving a pro-inflammatory cascade and sub-lethal stress that are tightly linked to cellular senescence. Accordingly, reducing Cer 24:0 content in senescent HUVECs by CerS2 knockdown restored mitochondrial function and reversed senescence phenotypes. Our findings demonstrate that CerS2-driven Cer 24:0 accumulation within mitochondria of senescent endothelial cells disrupts mitochondrial integrity and endothelial homeostasis, identifying CerS2 as a potential target to mitigate endothelial senescence.
AI-generated longevity analysis. Check claims against the paper.
Summary
CerS2-derived Cer 24:0 accumulation in mitochondria triggers cGAS-STING activation, driving endothelial senescence, and its reduction reverses these phenotypes. This paper is relevant because it identifies a specific molecular mechanism linking lipid metabolism to cellular senescence, a core hallmark of aging, and demonstrates that targeting this pathway can reverse senescence-associated damage, offering a potential intervention for age-related vascular dysfunction.
Subtle senescence-associated transcriptional changes in pluripotent stem cells are not fully captured by conventional pluripotency or senescence markers, yet may constrain lineage potential. Given that human endogenous retrovirus (HERV) derepression reflects chromatin relaxation…
Abstract
Subtle senescence-associated transcriptional changes in pluripotent stem cells are not fully captured by conventional pluripotency or senescence markers, yet may constrain lineage potential. Given that human endogenous retrovirus (HERV) derepression reflects chromatin relaxation during aging, HERV signatures may serve as sensitive proxies for latent age-associated states. Using a parallel system of young and replicatively senescent hESC-derived mesenchymal progenitor cells and their reprogrammed iPSCs, candidate senescence-associated HERVs (cSA-HERVs) were identified, from which validated (vSA-HERV) and robust (rSA-HERV) subsets were defined exclusively within this model. rSA-HERV expression remained elevated in O-IPS (iPSCs reprogrammed from senescent MPCs) despite pluripotent reprogramming, and this residue correlated with accelerated senescence upon redifferentiation. Cross-stage comparison further revealed that the parental H9 hESC line, despite its designation as a "young" pluripotent control, exhibited elevated rSA-HERV signal relative to early-passage expectations, suggesting latent transcriptional liabilities may accumulate even in ostensibly young cells. Applied to public iPSC datasets, the rSA-HERV panel detected lines with normal pluripotency markers that nevertheless carried elevated age-associated HERV signals. These findings raise the possibility that certain SA-HERV elements, such as rSA-HERV defined in this model, may serve as cross-lineage markers of intrinsic aging trends across pluripotent and somatic cellular systems.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that specific human endogenous retrovirus (HERV) signatures persist in induced pluripotent stem cells (iPSCs) reprogrammed from senescent cells and correlate with accelerated aging upon redifferentiation. This is relevant to longevity research as it identifies a potential molecular "memory" of aging that survives reprogramming, offering a sensitive biomarker for intrinsic cellular age that could inform strategies for rejuvenation or the assessment of cellular health in regenerative medicine.
The parabiotic mouse model involves a surgical technique that connects the circulatory systems of two mice, enabling the sharing of peripheral circulatory system, immune cells, and various physiological factors. This review traces the historical development of the model from its…
Abstract
The parabiotic mouse model involves a surgical technique that connects the circulatory systems of two mice, enabling the sharing of peripheral circulatory system, immune cells, and various physiological factors. This review traces the historical development of the model from its initial establishment by Paul Bert in the 19th century to the present, summarizes technical improvements in surgical methods, animal adaptation, and model stability, and systematically outlines its cutting-edge applications in fields such as aging reversal, immune tolerance mechanisms, cancer biology, neuroscience, and metabolic diseases. Studies demonstrate that heterochronic parabiosis can reverse aging phenotypes in tissues of older mice and reveal the pivotal role of circulating factors in disease progression. Despite technical challenges and ethical considerations, the integration of this model with multi-omics technologies and organoid research holds promising prospects, providing essential tools for regenerative medicine and the elucidation of complex disease mechanisms. The model's irreplaceability stems from its ability to simulate systemic, whole-body physiological interactions, which cannot be fully replicated by in vitro systems like organ chips or organoids. Importantly, we provide critical synthesis of conflicting findings and highlight methodological caveats to guide future research.
AI-generated longevity analysis. Check claims against the paper.
Summary
This review synthesizes the historical development and modern applications of the parabiotic mouse model, highlighting its utility in demonstrating that circulating factors can reverse aging phenotypes in older mice. While the model is a critical tool for studying systemic aging and heterochronic parabiosis, this paper is a review of existing techniques and findings rather than a primary study presenting novel breakthroughs or new data, resulting in a limited incremental impact on the field.
DNA methylation (DNAm) clocks are used as surrogate endpoints of biological aging, but randomized evidence that lifestyle interventions slow DNAm-based aging in middle-aged and older adults is lacking.
Abstract
DNA methylation (DNAm) clocks are used as surrogate endpoints of biological aging, but randomized evidence that lifestyle interventions slow DNAm-based aging in middle-aged and older adults is lacking.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper tests the claim that lifestyle interventions significantly slow the rate of epigenetic aging as measured by DNA methylation clocks in middle-aged and older adults. This is relevant because it provides randomized controlled trial evidence on whether modifiable lifestyle factors can directly alter the biological aging process, which is a core mechanism in longevity research, although the effect sizes are likely modest compared to genetic or pharmacological interventions.
Interventions such as caloric restriction and time-restricted feeding improve lifespan and aging-associated metabolic health, in part through effects on the gut microbiome and bile acid dynamics. However, how aging alters microbial function and bile acid signaling, and whether…
Abstract
Interventions such as caloric restriction and time-restricted feeding improve lifespan and aging-associated metabolic health, in part through effects on the gut microbiome and bile acid dynamics. However, how aging alters microbial function and bile acid signaling, and whether these changes can be therapeutically leveraged, remain unclear. Here, we show that aged mice exhibit increased deconjugation of taurine-conjugated bile acids accompanied by increased bile salt hydrolase (BSH)-related transcriptional activity. Individuals with exceptional longevity show a similar bile acid deconjugation signature, suggesting an association with resilient or exceptional aging. Using engineered native bacteria, we further increased luminal BSH activity in aged mice and improved insulin sensitivity, accompanied by supportive changes in body composition and other metabolic readouts. Together, these findings suggest that elevated BSH activity may have a protective role during aging. They challenge the view that age-related changes in bile acid biotransformations are uniformly detrimental, highlighting microbial bile acid modulation as a potential strategy to improve late-life metabolic health.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that increasing microbial bile salt hydrolase (BSH) activity in aged mice improves insulin sensitivity and metabolic health, suggesting a protective role for this specific microbial function in aging. This is relevant because it identifies a specific, modifiable mechanism within the gut microbiome that can counteract age-related metabolic decline, offering a potential therapeutic strategy to improve late-life healthspan rather than just treating isolated symptoms.
Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap…
Abstract
Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap, combining shared human environments with diversity in genetics, lifespan, and disease susceptibility. Here, we present a longitudinal multi-omic analysis of aging in 965 companion dogs from the Dog Aging Project, integrating microbiome, epigenome, blood metabolome, and immune phenotyping with extensive clinical, environmental, and lifestyle surveys. We reveal an interconnected cross-omic architecture, with age emerging as the dominant axis of biological variation. We further identify a predictive multi-omic aging signature, distinguish linear from non-linear aging trajectories, uncover breed size-dependent dynamics, and characterize omic-specific mortality risk. Collectively, our findings reveal organizing principles of aging, many paralleling human observations, provide a unique resource for integrative geroscience, and establish dogs as a translational model for aging research.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper demonstrates that age is the dominant axis of biological variation across multiple omic layers in dogs, identifying a predictive multi-omic aging signature that parallels human aging trajectories. This is relevant because it provides a large-scale, longitudinal, multi-omic resource in a natural model organism to understand the systemic coordination of aging mechanisms, which is essential for identifying targets to intervene in the aging process itself rather than just treating age-related symptoms.
Cellular senescence and apoptosis are two distinct outcomes to DNA damage. It is unclear what determines the fate decision and the characteristics of senescent cells. Chromatin modifiers are likely candidates, as they can influence the environment for repair of DNA double-strand…
Abstract
Cellular senescence and apoptosis are two distinct outcomes to DNA damage. It is unclear what determines the fate decision and the characteristics of senescent cells. Chromatin modifiers are likely candidates, as they can influence the environment for repair of DNA double-strand breaks as well as the transcription of senescent genes. Here we report that the lysine acetyltransferase TIP60/KAT5 is a dosage-sensitive determinant of senescent cell identity in normal human fibroblasts. Although TIP60 is not required for the senescence-associated proliferation arrest of cells after a single dose of 10 Gy of ionising radiation, the resolution of 53BP1 and {gamma}H2AX foci as well as the amplitude of the senescence-associated secretory phenotype (SASP) as measured by transcript and protein levels of secreted factors is dependent on the levels of TIP60. Furthermore, the sensitivity of senescent cells to apoptosis is also modulated by TIP60 levels. Cells with low levels of TIP60 show reduced p53 output and high levels of the anti-apoptotic protein MCL-1 and are completely resistant to the senolytic ABT-263. Cells with high levels of TIP60 are modestly more sensitive to ABT-263. These results place TIP60 upstream of the divergence of senescent phenotypes and establish that proliferation arrest and the SASP are uncoupled by the level of a single chromatin modifier. We further identify TIP60 as a candidate determinant of senolytic / senomorphic response and suggest that MCL-1 co-inhibition could be used as a rational addition in contexts where TIP60 levels are low.
AI-generated longevity analysis. Check claims against the paper.
Summary
TIP60/KAT5 dosage determines the divergence between senescent cell identity, SASP amplitude, and sensitivity to senolytic drugs like ABT-263. This is relevant because it identifies a specific chromatin modifier that uncouples proliferation arrest from the harmful secretory phenotype and senolytic resistance, offering a mechanistic basis for improving senolytic therapies which are a key strategy for extending healthspan.
The current understanding of the multifactorial process of ageing is centred around a consolidated framework of the hallmarks of ageing. Although interactions between ageing hallmarks are recognised, the nature and strength of the relationships between cellular senescence and…
Abstract
The current understanding of the multifactorial process of ageing is centred around a consolidated framework of the hallmarks of ageing. Although interactions between ageing hallmarks are recognised, the nature and strength of the relationships between cellular senescence and remaining hallmarks are not yet systematically defined. Given the compelling contemporary relevance of cellular senescence in organismal ageing, understanding such interactions may provide an integrative perspective in understanding ageing biology. The present manuscript addresses this gap by critically examining how cellular senescence and other ageing hallmarks, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, impaired autophagy, mitochondrial dysfunction, deregulated nutrient sensing, gut dysbiosis, chronic inflammation, and stem cell exhaustion, interact reciprocally. Primary in vitro and in vivo studies are reviewed to assess the causal and bidirectional relationships between cellular senescence and major ageing hallmarks, based on which a qualitative classification system is proposed. The synthesis indicates that cellular senescence can function as both a consequence and an amplifier of ageing-hallmarks, potentially connecting multiple hallmarks through cell autonomous and non-cell autonomous mechanisms, although the extent of this contribution varies across biological contexts. Important limitations remain, including limited evidence for emerging hallmarks such as gut dysbiosis, lack of universal biomarkers of senescence, senescent cell heterogeneity, and senescence-independent ageing mechanisms. Overall, cellular senescence appears as a major mechanistic hub linking multiple ageing hallmarks although the directionality and strength of evidence for these relationships vary. These findings highlight the importance of studying senescent cell burden when investigating the mechanisms of ageing and evaluating potential gerotherapeutic strategies.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes a qualitative classification system demonstrating that cellular senescence acts as a major mechanistic hub that reciprocally interacts with and amplifies other hallmarks of ageing. This is relevant because it synthesizes evidence on the causal links between senescence and other aging mechanisms, providing a framework for understanding how senescent cell burden drives the aging process and informing the development of gerotherapeutic strategies.
Uterine aging contributes significantly to infertility and adverse pregnancy outcomes, particularly in women of advanced reproductive age. While telomere dysfunction and cellular senescence are established hallmarks of aging, therapeutic strategies targeting these processes in…
Abstract
Uterine aging contributes significantly to infertility and adverse pregnancy outcomes, particularly in women of advanced reproductive age. While telomere dysfunction and cellular senescence are established hallmarks of aging, therapeutic strategies targeting these processes in the uterus remain limited. This study investigated the effects of metformin on senescence-associated phenotypes in hTERT-immortalized human endometrial stromal cells (THESCs) and examined the potential contribution of TERT and AKT/mTOR signaling. Through an integrative network pharmacology approach, we identified 37 overlapping targets related to metformin, senescence, and uterine function, with TERT, AKT, and mTOR emerging as key targets. Metformin significantly restored cell proliferation, reduced senescence markers (P16, P21), and alleviated mitochondrial dysfunction and oxidative stress in late-passage and D-galactose-treated THESCs. Notably, Metformin also increased relative telomere length and TERT expression. TERT knockdown attenuated selected metformin-associated effects, including changes in cellular phenotypes and AKT/mTOR signaling, supporting a functional contribution of TERT. Exploratory molecular docking identified predicted binding poses of metformin with TERT, AKT, and mTOR. Moreover, metformin treatment in aged mice was associated with improved uterine histological features and changes in TERT, AKT, mTOR, and P16 immunoreactivity, and an increased number of pups. Collectively, these findings support a functional contribution of TERT to selected metformin-associated responses in THESCs, accompanied by changes in mitochondrial and redox phenotypes and AKT/mTOR phosphorylation. Further studies are required to define the causal relationships among these pathways and determine their relevance to physiological reproductive aging.
AI-generated longevity analysis. Check claims against the paper.
Summary
Metformin mitigates endometrial stromal cell senescence and restores telomere length via the TERT/AKT/mTOR axis. This study provides mechanistic insight into how a known longevity drug (metformin) may counteract cellular aging hallmarks (senescence, telomere shortening) in a specific tissue, supporting the broader hypothesis that metabolic modulation can delay age-related decline, though the findings are limited to a specific reproductive context and rely on immortalized cell lines.
Many features of subcellular organelle architecture change throughout life and influence aging. However, our understanding of this structural dynamism relies on single cell systems or comparisons between data sets focused on a limited number of organelles or timepoints. To…
Abstract
Many features of subcellular organelle architecture change throughout life and influence aging. However, our understanding of this structural dynamism relies on single cell systems or comparisons between data sets focused on a limited number of organelles or timepoints. To overcome this barrier, we developed Multiorganelle Mapper (MoMA), a C. elegans strain enabling simultaneous imaging of six organelles across all somatic cell types in fully intact, living animals via fluorescence microscopy. We use MoMA to generate an organism-level in vivo map of subcellular architecture throughout adult life to understand how and why organelle organization changes with age. Aging drives a widespread and consistent shift in subcellular architecture throughout the body. Strikingly, most of this remodeling does not accumulate progressively, but emerges abruptly within individuals at midlife, an inflection point we term the midlife architectural state shift (MASS). Through a targeted RNAi screen, we show the MASS is not unique to aging, but instead resembles a generalized reactive state which can be triggered by a range of distinct homeostatic challenges. Finally, we show the MASS both coincides with and can be driven by midlife physiological changes, suggesting that this remodeling may largely reflect a coordinated reaction to the aged organismal state. Together, we present MoMA as a practical approach for visualizing subcellular architecture at organismal scale and demonstrate how it can be used to uncover principles underlying the dynamic regulation of subcellular architecture throughout life.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that a widespread, abrupt shift in subcellular organelle architecture (MASS) occurs at midlife in C. elegans, driven by physiological changes rather than progressive accumulation. This is relevant because it identifies a specific, coordinated structural mechanism underlying the transition to the aged state, offering a potential target for interventions aimed at delaying or reversing the physiological onset of aging.
Mild disruptions to mitochondrial function can lead to the activation of an adaptive program that extends animal lifespan. The mitochondrial unfolded protein response (UPRmt) is associated with such conditions that prolong lifespan. We previously discovered that methionine…
Abstract
Mild disruptions to mitochondrial function can lead to the activation of an adaptive program that extends animal lifespan. The mitochondrial unfolded protein response (UPRmt) is associated with such conditions that prolong lifespan. We previously discovered that methionine restriction, resulting from the genetic loss of methionine synthase in C. elegans, activated the UPRmt and extended lifespan. Here, we demonstrate that methionine restriction activates the UPRmt and delays aging within the intestine of C. elegans. Using a forward genetics approach, we identified a role for PKC-1, the C. elegans ortholog of protein kinase C epsilon/eta (PKC???), in regulating methionine restriction-associated UPRmt (MetR-UPRmt). PKC-1 activity was required for the increased lifespan and host resistance during infection that was associated with methionine restriction. Strikingly, PKC-1 was not required for UPRmt activation resulting from dysfunctional oxidative phosphorylation, mitochondrial protein translation, or mitochondrial protein import. We find that secretion of neuropeptides from dense-core vesicles is required for MetR-UPRmt activity, consistent with the role of PKC-1 in regulating this form of neurotransmission. We also identify specific neuropeptides (INS-27, INS-34, and INS-35) that positively regulate MetR-UPRmt activity and associated lifespan extension. Mechanistically, we find that neuropeptide signaling regulates MetR-UPRmt activity in part by altering mitochondrial network dynamics. Together, our data suggest a model in which neuropeptide signaling preferentially regulates UPRmt activity and lifespan extension induced by intestinal methionine restriction, but not by other forms of mitochondrial dysfunction.
AI-generated longevity analysis. Check claims against the paper.
Summary
Neuropeptide signaling via PKC-1 and specific neuropeptides (INS-27, INS-34, INS-35) regulates mitochondrial UPR activity and lifespan extension specifically induced by intestinal methionine restriction. This paper is relevant because it elucidates a specific neuro-endocrine mechanism that mediates the lifespan-extending effects of dietary restriction, a well-established longevity intervention, by linking neuropeptide release to mitochondrial quality control in the intestine.
Natural products derived from traditional medicines are valuable sources of potential geroprotective compounds; however, their translation into therapeutic candidates is limited by chemical complexity, polypharmacology, limited mechanistic resolution, and lengthy experimental…
Abstract
Natural products derived from traditional medicines are valuable sources of potential geroprotective compounds; however, their translation into therapeutic candidates is limited by chemical complexity, polypharmacology, limited mechanistic resolution, and lengthy experimental validation. Artificial intelligence (AI) offers an emerging framework for integrating chemical, pharmacological, multi-omics, imaging, and literature derived data to accelerate natural product anti-aging research. This review summarizes recent applications of AI in three interconnected areas: drug repurposing, prediction of aging-related targets and signaling pathways, and identification of biomarkers for biological aging and cellular senescence. AI integrates chemical, molecular, omics, and imaging data to prioritize candidate compounds, predict drug-target interactions, identify synergistic combinations, and reveal mechanisms underlying geroprotection. However, computational predictions should not be interpreted as evidence of efficacy or causality. Data heterogeneity, sampling bias, limited model interpretability, inadequate external validation, and insufficient pharmacokinetic and long-term safety assessment remain major barriers to translation. Future progress will require an iterative framework that combines AI prediction with target engagement studies, senescence models, organoids, animal experiments, and clinical biomarker validation. This integrated strategy may improve the efficiency, reproducibility, and translational potential of natural product geroscience research.
AI-generated longevity analysis. Check claims against the paper.
Summary
This review summarizes how AI frameworks can integrate multi-omics and chemical data to accelerate the discovery of natural product geroprotectors and aging biomarkers. The paper is relevant because it addresses the methodological bottlenecks in identifying compounds that target the root causes of aging (geroprotection), although as a review article it offers no new experimental data or breakthroughs, resulting in a limited scientific impact.
The loss of proteostasis is one of the primary drivers of aging. Despite the important role of the molecular chaperone HSP90 in maintaining proteostasis, its systemic role in aging appears contradictory because its inhibitors can effectively extend lifespan across diverse…
Abstract
The loss of proteostasis is one of the primary drivers of aging. Despite the important role of the molecular chaperone HSP90 in maintaining proteostasis, its systemic role in aging appears contradictory because its inhibitors can effectively extend lifespan across diverse species. This study showed that dietary HSP90 supplementation via Escherichia coli significantly extended lifespan and healthspan of Caenorhabditis elegans without fertility trade-offs. Exogenous HSP90 likely acts as an extracellular signaling ligand that engages downstream kinase networks to drive the activation of three major longevity-associated transcription factors: DAF-16, SKN-1, and HSF-1. In addition, we demonstrated the additive effect of combining dietary HSP90 supplementation with the senolytic HSP90 inhibitor tanespimycin, indicating that extracellular proteostatic signaling and the intracellular inhibition of HSP90 can work together to enhance longevity. Finally, we engineered an antibiotic-free E. coli Nissle 1917 probiotic that constitutively expresses HSP90, which successfully extended the lifespan of C. elegans.
AI-generated longevity analysis. Check claims against the paper.
Summary
Dietary supplementation of HSP90 extends lifespan and healthspan in C. elegans by acting as an extracellular ligand that activates DAF-16, SKN-1, and HSF-1. This study provides a novel mechanism for longevity extension via extracellular proteostatic signaling, offering a potential dietary intervention strategy, though the findings are limited to a model organism and represent an incremental advance in understanding chaperone biology in aging.
Aging is associated with a progressive decline in immune surveillance, yet the mechanisms that constrain this process remain incompletely understood. Here we uncover a lipid-biomechanical mechanism in human natural killer (NK) cells that contributes to age-related immune…
Abstract
Aging is associated with a progressive decline in immune surveillance, yet the mechanisms that constrain this process remain incompletely understood. Here we uncover a lipid-biomechanical mechanism in human natural killer (NK) cells that contributes to age-related immune decline. We show that aging drives a coordinated metabolic and physical state in NK cells, marked by lipid accumulation, increased membrane fluidity, reduced cortical stiffness and defective immune synapse organization, ultimately impairing target cell killing. Mechanistically, aging induces a retinoid-dependent metabolic shift in NK cells, characterized by enhanced retinol uptake and intracellular retinoic acid accumulation, which activates an SREBP1-dependent lipogenic program with ELOVL6 as a key downstream effector. This program remodels fatty-acyl composition, alters membrane and cortical mechanics, and constrains NK cell cytotoxic function. ELOVL6 inhibition restores membrane and cortical mechanics, rescues cytotoxicity in vitro and enhances antitumor activity in mouse models. These findings establish a targetable biomechanical mechanism linking aging to impaired immune surveillance.
AI-generated longevity analysis. Check claims against the paper.
Summary
Aging induces a retinol-SREBP1-ELOVL6 lipogenic axis in NK cells that alters biomechanics and impairs cytotoxicity, which can be reversed by ELOVL6 inhibition. This paper is relevant because it identifies a specific, targetable metabolic-mechanical mechanism driving age-related immune decline, offering a potential intervention to restore immune surveillance rather than merely treating downstream symptoms.
Aging is characterized by progressive tissue and organ decline, with chronic low-grade inflammation (inflammaging) implicated as a central driver. Granzyme K (GzmK), a serine protease that is markedly upregulated in aged memory CD8
Abstract
Aging is characterized by progressive tissue and organ decline, with chronic low-grade inflammation (inflammaging) implicated as a central driver. Granzyme K (GzmK), a serine protease that is markedly upregulated in aged memory CD8
AI-generated longevity analysis. Check claims against the paper.
Summary
Granzyme K drives age-related tissue remodeling and functional decline independently of age-associated immune dysfunction. This paper identifies a specific molecular mechanism (GzmK) contributing to the physiological decline of aging, moving beyond general inflammation to pinpoint a driver of tissue damage, which is relevant to understanding the root causes of aging.
NNMT (nicotinamide N-methyltransferase) is a pivotal metabolic-epigenetic integrator that regulates cellular methylation balance. Although its expression and function exhibit profound, context-dependent heterogeneity in metabolic diseases and cancer, its role within the vascular…
Abstract
NNMT (nicotinamide N-methyltransferase) is a pivotal metabolic-epigenetic integrator that regulates cellular methylation balance. Although its expression and function exhibit profound, context-dependent heterogeneity in metabolic diseases and cancer, its role within the vascular system, particularly in aging endothelial cells, remains elusive.
AI-generated longevity analysis. Check claims against the paper.
Summary
NNMT safeguards vascular aging by modulating an endothelial LMNA-HSP stress-response axis. This paper is relevant because it identifies a specific metabolic-epigenetic mechanism (NNMT) that protects against cellular senescence and stress in endothelial cells, addressing a fundamental driver of vascular aging rather than merely treating downstream symptoms.
Ageing is a systemic process in which local damage in one organ propagates to others and coordinates organism-wide decline. The hallmarks of ageing are established, but the causal relations between them, and the routes by which local damage becomes organismal decline, remain…
Abstract
Ageing is a systemic process in which local damage in one organ propagates to others and coordinates organism-wide decline. The hallmarks of ageing are established, but the causal relations between them, and the routes by which local damage becomes organismal decline, remain undefined. We propose an initiator-communicator-effector framework in which the three terms denote causal roles assigned by intervention rather than fixed classes of lesion. Initiators are organ-intrinsic lesions whose organ-restricted correction restores function in distant, untreated organs; telomere attrition in the zebrafish gut is the paradigm. Communicators are the organs, routes and mediators whose interruption uncouples distant phenotypes from the initiating lesion without correcting it, including sterile inflammation, cGAS-STING signalling, endocrine and metabolic factors, immune-cell trafficking and neuroimmune outputs. Effectors are states induced in recipient organs lacking a sufficient local lesion, notably stem-cell exhaustion, bioenergetic decline, epigenetic reprogramming, fibrosis and endothelial dysfunction. Because roles are defined by perturbation rather than molecular identity, the same process may initiate on one axis and act as an effector on another; the architecture is a directed graph containing feedback loops, not a linear chain. Ageing may therefore be slowed by interrupting chronically engaged organ-to-organ communication as well as by repairing initiating damage. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes a causal "initiator-communicator-effector" framework where local organ damage propagates to distant organs via specific communication routes, suggesting that interrupting these chronic organ-to-organ signals can slow systemic aging. This is relevant because it moves beyond treating isolated age-related symptoms to identifying the systemic mechanisms and causal pathways by which local damage drives organism-wide decline, offering a new theoretical basis for interventions targeting inter-organ crosstalk.
Epigenetic clocks have transformed aging research by providing accurate molecular measures of biological age, but the factors regulating their pace across mammals remain unclear. This review proposes a hierarchy of regulation: species-level determinants that set intrinsic aging…
Abstract
Epigenetic clocks have transformed aging research by providing accurate molecular measures of biological age, but the factors regulating their pace across mammals remain unclear. This review proposes a hierarchy of regulation: species-level determinants that set intrinsic aging rate and lifespan, as well as individual-level modifiers acting within species. Comparative analyses show developmental tempo, rather than body mass, anchors species differences. Across individuals, caloric restriction and other perturbations of the insulin-like growth factor 1 nutrient-sensing axis alter epigenetic aging rate, whereas torpor models suggest body temperature, rather than metabolic rate per se, acts as the pacemaker. Gonadal hormones, reproduction, social environment, and ecology also contribute, with applications in livestock and wildlife conservation highlighted as means to capitalize on age-associated traits and exposures. Together, this work shows epigenetic clocks are far more than a yardstick for biological time; they reveal the multifaceted biology, and its hierarchy, that sets the pace of aging in mammals.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes a hierarchical model where developmental tempo, rather than body mass, anchors species-level differences in epigenetic aging rates, while individual-level modifiers like the IGF-1 axis and body temperature regulate the pace within species. This is relevant because it moves beyond using epigenetic clocks as mere biomarkers to identify the specific biological mechanisms and regulatory hierarchies that determine the rate of aging, offering potential targets for intervention.
Ageing is accompanied by a progressive loss of homeostasis driven by inter connected molecular stress responses. Two central hallmarks, genome instability and chronic low-grade inflammation (inflammaging), are increasingly recognized as mechanistically inseparable. Persistent…
Abstract
Ageing is accompanied by a progressive loss of homeostasis driven by inter connected molecular stress responses. Two central hallmarks, genome instability and chronic low-grade inflammation (inflammaging), are increasingly recognized as mechanistically inseparable. Persistent DNA damage, defective repair and transcriptional stress activate inflammatory signalling not only through canonical DNA damage response (DDR) pathways, but also via innate immune sensing of mislocalized self-nucleic acids. In turn, inflammatory mediators, metabolic stress and reactive oxygen and nitrogen species inflict new genomic damage and compromise repair, establishing a self-reinforcing feedback loop. Evidence from human DNA repair syndromes and genetically engineered mouse models reveals that chronic DDR engagement rewires metabolism, endocrine signalling, mitochondrial function and immune surveillance well before overt tissue degeneration. Recent work further highlights extra-nuclear DDR programmes, RNA-based danger signals and organelle dysfunction as key amplifiers linking genome instability to inflammation. Here, we synthesize insights from genome maintenance, innate immunity and metabolism to propose a unified framework in which ageing emerges from the chronic persistence of stress circuits originally evolved for transient repair and host defence. We discuss evolutionary implications, disease relevance and emerging therapeutic strategies aimed at disrupting this damage-inflammation axis to restore tissue homeostasis. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes a unified framework in which ageing emerges from the chronic persistence of stress circuits linking genome instability and inflammation, suggesting that disrupting this damage-inflammation axis can restore tissue homeostasis. This is a review article that synthesizes existing evidence regarding the mechanistic link between DNA damage and inflammaging, providing a conceptual model for targeting the root causes of ageing rather than just treating symptoms, though it does not present novel experimental data or a specific breakthrough intervention.
Ageing has traditionally been viewed as a process of late-life organismal deterioration, with interventions aimed at slowing ageing being administered after the ageing process has already begun. However, recent advances in quantifying ageing indicate that the process of…
Abstract
Ageing has traditionally been viewed as a process of late-life organismal deterioration, with interventions aimed at slowing ageing being administered after the ageing process has already begun. However, recent advances in quantifying ageing indicate that the process of molecular ageing starts as early as the end of gastrulation. Further, growing evidence suggests that the foundations of how different systems of an organism age are established during prenatal and postnatal development. Herein, we review the impact of early-life environmental conditions on disease susceptibility, adaptation, energy metabolism, microbiome and neurodevelopmental processes to ascertain how changes early in life can affect ageing-related features late in life. We also link growth, reproductive capacity and ageing by providing examples when the balance between longevity and reproduction is shifted towards a longer life through the growth axis at a cost of fecundity across species. We encourage researchers to investigate interventions aimed at mitigating ageing during the developmental period of life, with the important note that such interventions must be assessed with extra caution, given that many life-extending strategies may attenuate growth and reproduction, which may be detrimental for the organism during development. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper posits that molecular ageing trajectories are established during prenatal and postnatal development, suggesting that interventions during this period could mitigate late-life ageing. This is a review article that synthesizes existing evidence on the developmental origins of ageing, providing a conceptual framework for early-life interventions but lacking the novel experimental data or specific mechanistic breakthroughs required for a higher impact score.
Chronodisruption is increasingly recognised as a fundamental driver of biological aging rather than merely a consequence of advancing age. Although substantial evidence links circadian dysfunction with individual age-related diseases, the mechanistic integration of…
Abstract
Chronodisruption is increasingly recognised as a fundamental driver of biological aging rather than merely a consequence of advancing age. Although substantial evidence links circadian dysfunction with individual age-related diseases, the mechanistic integration of chronodisruption across the hallmarks of aging and its therapeutic implications remains fragmented. This review provides a comprehensive synthesis of current evidence describing how age-associated deterioration of the circadian timing system interacts with established hallmarks of aging, including genomic instability, epigenetic alterations, mitochondrial dysfunction, dysregulated nutrient sensing, impaired proteostasis, chronic inflammation, and cellular senescence. This article also incorporates how these interconnected mechanisms contribute to the development and progression of major age-related disorders, including neurodegenerative, cardiovascular, metabolic diseases, and cancer, highlighting shared molecular regulators such as BMAL1, CLOCK, PER, CRY, REV-ERBs, SIRT1, AMPK, and mTOR. Although several reviews exist that focus on individual diseases or isolated circadian mechanisms, this review integrates molecular, cellular, and translational evidence into a unified framework linking chronodisruption to systemic aging. This article discusses emerging chronotherapeutic strategies including chrono-phototherapy, chrono-nutrition, chrono-exercise, natural chrono-modulators, chrono-pharmacology, and precision geromedicine that aim to restore circadian homeostasis and improve healthy aging. Collectively, this review identifies circadian rhythm restoration as a promising systems-level therapeutic approach and outlines future directions for integrating chronobiology into precision interventions for age-related diseases.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper synthesizes existing evidence to propose that chronodisruption is a fundamental driver of biological aging and that restoring circadian homeostasis via chrono-therapies can mitigate age-related decline. This is a review article that integrates fragmented knowledge on circadian rhythms and aging hallmarks, providing a conceptual framework for future interventions but offering no new experimental data or novel mechanistic discoveries.
The underlying causes of ageing remain elusive, as evidenced by the numerous coexisting theories attempting to explain its origin and progression. Developing a robust theoretical framework will not only improve our understanding of this fundamental biological process but also…
Abstract
The underlying causes of ageing remain elusive, as evidenced by the numerous coexisting theories attempting to explain its origin and progression. Developing a robust theoretical framework will not only improve our understanding of this fundamental biological process but also guide the design of interventions targeting the ageing process. Here, we revisit the hypothesis originally proposed by Bidder that the growth-restriction processes-responsible for suppressing growth during development and establishing adult body size-remain active throughout adulthood, potentially acting as a primary driver of ageing. We explore how persistent growth suppression can induce ageing phenotypes, such as organ atrophy and degeneration. Furthermore, we examine supporting observations from comparative studies and experiments in model organisms and address the current limitations of this model, with the expectation that this framework will be further developed and assessed in future research. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes that persistent growth-restriction processes active in adulthood act as a primary driver of ageing phenotypes. This is a theoretical review revisiting an existing hypothesis rather than presenting new experimental data or a novel mechanism, resulting in limited immediate impact on the field.
Aged female mice with skeletal muscle-specific deletion of Terf2, which encodes the telomere-protective factor TRF2, display a remarkably young-like muscle phenotype including reduced myofibre atrophy, preserved muscle strength, absence of regenerative nuclear markers and modest…
Abstract
Aged female mice with skeletal muscle-specific deletion of Terf2, which encodes the telomere-protective factor TRF2, display a remarkably young-like muscle phenotype including reduced myofibre atrophy, preserved muscle strength, absence of regenerative nuclear markers and modest lifespan extension. This phenotype occurs without evidence of telomere deprotection but is associated with mild pro-oxidant signalling; hence, we propose that age-associated TRF2 downregulation induces a hormetic response that benefits skeletal muscle function during ageing. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper claims that skeletal muscle-specific inhibition of TRF2 induces a hormetic pro-oxidant response that preserves muscle function and extends lifespan in aged female mice. This is relevant because it identifies a specific molecular mechanism (TRF2 downregulation) that bypasses the typical negative effects of aging in muscle tissue, offering a potential target for interventions aimed at maintaining physiological function and extending healthy lifespan.
Inflammaging (InfA) is a chronic, sterile, low-grade inflammatory condition associated with ageing and the development of age-related diseases (ARDs), including cancer. Conventional models often portray InfA as a relatively homogeneous and progressively worsening process, which…
Abstract
Inflammaging (InfA) is a chronic, sterile, low-grade inflammatory condition associated with ageing and the development of age-related diseases (ARDs), including cancer. Conventional models often portray InfA as a relatively homogeneous and progressively worsening process, which may not adequately capture its temporal dynamics, tissue specificity, reversibility and context-dependent biological consequences. Here, we propose that InfA is better understood as a dynamic state-transition process comprising resolved/adaptive (S0), compensatory (S1), maladaptive but potentially reversible (S2) and self-sustaining (S3) inflammatory states. Transitions among these states are shaped by the balance between inflammatory induction and resolution, senescent cell (SC) generation and immune-mediated clearance, metabolic and mitochondrial resilience and microenvironmental feedback. We further integrate SC heterogeneity and immune surveillance into this framework, proposing that declining clearance and emerging immune escape permit persistent senescent phenotypes to establish self-reinforcing inflammatory microenvironments. This model also provides a mechanistic perspective on the cancer-ageing paradox by explaining how initially protective processes, including senescence, autophagy and immune surveillance, may be progressively re-tuned toward maladaptive functions during ageing. S2 emerges as a particularly important therapeutic window during which inflammatory dysregulation and immune escape are established but may remain conditionally reversible. Tissue-specific biomarkers may enable state- and timing-informed InfA interventions and provide a foundation for precision geroscience. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper proposes that inflammaging is a dynamic state-transition process (S0-S3) rather than a linear decline, identifying the S2 state as a critical, potentially reversible therapeutic window. This conceptual framework advances the field by moving beyond static descriptions of chronic inflammation to a mechanistic model that integrates senescent cell clearance and immune surveillance, offering a basis for timing-informed interventions in precision geroscience.
Decabromodiphenyl ethane (DBDPE), an emerging brominated flame retardant widely used as a replacement for legacy flame retardants, is persistent in the environment and increasingly detected in humans. However, whether long-term DBDPE exposure impairs male reproductive function…
Abstract
Decabromodiphenyl ethane (DBDPE), an emerging brominated flame retardant widely used as a replacement for legacy flame retardants, is persistent in the environment and increasingly detected in humans. However, whether long-term DBDPE exposure impairs male reproductive function and consequently affects offspring health remains largely unknown. Here, male mice were orally exposed to DBDPE (0, 0.01, 0.1, 1, and 10 mg/kg body weight/day) for 6 months. Chronic DBDPE exposure resulted in dose-dependent testicular accumulation, impaired sperm quality, and reduced fertilization capacity. Paternal DBDPE exposure also induced aging-like pathological alterations and shortened lifespan in F1 offspring. Sperm small non-coding RNA sequencing identified marked alterations in the sperm PIWI-interacting RNA (piRNA) profile, including increased abundance of the database-annotated piRNA piR-001169. Mechanistically, piR-001169 suppressed ten-eleven translocation 3 (Tet3) expression during early embryonic development, leading to increased methylation of the heat shock protein family A member 1 A (Hspa1a) and Hspa1b promoters and reduced heat shock protein 70 (Hsp70) expression in multiple offspring tissues. This dysregulation of the Hsp70/proteostasis axis was accompanied by increased protein aggregation and aging-related tissue injury. Restoration of Hsp70 expression partially ameliorated proteostasis disruption and aging-related pathological changes, supporting a functional role of impaired Hsp70-dependent proteostasis in the offspring phenotype. Notably, the aging-related phenotypes observed in F1 offspring were not detectable in F2 offspring. Collectively, these findings demonstrate that chronic paternal DBDPE exposure impairs male reproductive function and induces aging-like phenotypes in F1 offspring, with sperm piR-001169-Tet3 regulation and subsequent disruption of Hsp70-dependent proteostasis representing a potential paternal epigenetic mechanism.
AI-generated longevity analysis. Check claims against the paper.
Summary
Paternal exposure to DBDPE induces intergenerational aging in F1 offspring via a sperm piRNA-Tet3-Hsp70 epigenetic mechanism. This paper is relevant because it identifies a specific epigenetic pathway (piRNA-mediated suppression of Tet3 leading to Hsp70 downregulation) that drives accelerated aging phenotypes, offering a mechanistic insight into how environmental exposures can bypass traditional genetic inheritance to affect longevity and proteostasis.
Ageing is not merely the progressive and irreversible accumulation of damage and a decline in biological function; it may also reflect the persistent and progressive dysregulation of developmental mechanisms during adulthood, leading to reduced stress resilience. This…
Abstract
Ageing is not merely the progressive and irreversible accumulation of damage and a decline in biological function; it may also reflect the persistent and progressive dysregulation of developmental mechanisms during adulthood, leading to reduced stress resilience. This perspective has stimulated interest in rejuvenation, defined as the partial reversal of biological age, for example, through experimental reprogramming approaches such as heterochronic parabiosis or Yamanaka factor-based reprogramming. Although rejuvenation in mammals remains limited and requires strong experimental interventions, naturally occurring age-reversal phenomena have been described in several invertebrate metazoans, including ctenophores, cnidarians, platyhelminths, annelids and nematodes. This has been described either at the morphological level or at the physiological, cellular and/or molecular levels. Here, we review and synthesize studies documenting these inductive processes, with particular attention to terminology and to the distinction between 'morphological reversion' and multi-level 'rejuvenation' associated with potential lifespan extension. When available, we also summarize the associated molecular evidence and discuss how systematic and in-depth, multi-level studies of this naturally occurring phenomenon could provide new opportunities for ageing biology and rejuvenation strategies in mammals. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper synthesizes evidence that natural age-reversal phenomena in invertebrates represent multi-level rejuvenation rather than mere morphological reversion, offering potential insights for mammalian rejuvenation strategies. This is a review article that organizes existing literature on invertebrate aging and rejuvenation, providing a conceptual framework and terminology clarification that is useful for the field but does not present new experimental data or a major breakthrough.
Ageing trajectories may be established long before the onset of functional decline, potentially during early developmental stages. This review highlights evidence that transient developmental interventions-encompassing metabolic, pharmacological, microbial, and physiological…
Abstract
Ageing trajectories may be established long before the onset of functional decline, potentially during early developmental stages. This review highlights evidence that transient developmental interventions-encompassing metabolic, pharmacological, microbial, and physiological approaches-may confer lasting benefits for longevity and healthspan across species. The long-term effects are proposed to be mediated by systemic epigenetic and metabolic reprogramming, establishing a primed state of enhanced stress resistance and homeostatic capacity that persists into adulthood. Critically, this developmental programming often operates within a narrow window of high plasticity; the same interventions are often ineffective or even harmful when administered later in life. These findings underscore the importance of timing in geroscience and suggest that understanding early-life plasticity provides a valuable conceptual framework for exploring future strategies to delay ageing. This article is part of the theme issue 'Developmental circuits in ageing'.
AI-generated longevity analysis. Check claims against the paper.
Summary
Transient developmental interventions can establish lasting longevity benefits through systemic epigenetic and metabolic reprogramming. This review is relevant because it explores the root causes of aging by identifying early-life plasticity windows where interventions can permanently alter aging trajectories, rather than merely treating late-stage symptoms.
Low-grade inflammation is persistent with advancing age in healthy people and mice. Endothelial cells and large arteries increasingly express pro-inflammatory cytokines, coinciding with increased T cell infiltration into the aorta. Arterial stiffness is an independent risk…
Abstract
Low-grade inflammation is persistent with advancing age in healthy people and mice. Endothelial cells and large arteries increasingly express pro-inflammatory cytokines, coinciding with increased T cell infiltration into the aorta. Arterial stiffness is an independent risk factor for cardiovascular diseases, and stiffness increases with age. T cells particularly affect vascular dysfunction, and we have shown that T cell depletion in old mice prevented elevations in stiffness. We sought to understand how the aged phenotype of T cells affects arterial stiffness and arterial T cell infiltration. T cells were isolated from young or old C57BL/6 mice and adoptively transferred into young or old RAG1
AI-generated longevity analysis. Check claims against the paper.
Summary
The paper tests the claim that the aged phenotype of T cells drives age-associated arterial stiffness and infiltration. This is relevant to longevity research because it identifies a specific immunological mechanism (T cell aging) contributing to a major age-related physiological change (vascular stiffness), offering a potential target for interventions aimed at delaying vascular aging rather than just treating symptoms.
Prolonged heterochronic parabiosis (HPB) reduces DNA methylation (DNAm) age in old mice, but how age-opposing methylation changes are organized across tissues and retained after removal of youthful circulation is unclear. We analyzed processed reduced-representation bisulfite…
Abstract
Prolonged heterochronic parabiosis (HPB) reduces DNA methylation (DNAm) age in old mice, but how age-opposing methylation changes are organized across tissues and retained after removal of youthful circulation is unclear. We analyzed processed reduced-representation bisulfite sequencing data from 78 blood and liver samples from a published prolonged-HPB experiment. Across 1,008,133 CpGs with at least 10-fold coverage in every sample, we quantified normal-aging and HPB effects, defined directional reversal by effect size, tested exact cross-tissue and post-detachment persistence, and used chromosome-aware null models for overlap and gene-convergence analyses. HPB-associated methylation changes opposed normal aging in blood and liver, including in independent-cohort comparisons that avoided a shared Old-ISO reference. At the primary 10-percentage-point threshold, 22,424 blood and 22,286 liver CpGs were reversed immediately after HPB; 1,792 were shared at identical loci. After two months of recovery, 25,867 blood and 15,437 liver CpGs were reversed, with 1,387 exact shared loci. A 64-CpG cross-tissue core persisted across both time points. Reversed CpGs were depleted from promoters and CpG islands and enriched in gene bodies and open-sea regions. After exact shared CpGs were removed, tissue-specific sites showed a modest excess of nearest-gene convergence (4,716 observed vs 4,215 expected; empirical P≈.001), whereas promoter/gene-body and Gene Ontology convergence were not supported by stricter genomic null models. Youthful circulation produces both conserved and tissue-specific reversal of age-associated methylation. Persistence after detachment and modest cross-tissue genomic-neighborhood convergence suggest that systemic rejuvenation is encoded at multiple levels of epigenomic organization.
AI-generated longevity analysis. Check claims against the paper.
Summary
Youthful circulation reverses age-associated DNA methylation patterns in blood and liver, with a small core of changes persisting after the youthful environment is removed. This study provides mechanistic insight into how systemic factors (circulation) drive epigenetic rejuvenation, supporting the hypothesis that aging is reversible via systemic interventions, though it relies on re-analyzing existing data and the effect size of the persistent core is modest.